"HIV Fusion Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS.
| Descriptor ID |
D023581
|
| MeSH Number(s) |
D27.505.519.957.500 D27.505.954.122.388.077.088.209 D27.505.954.122.388.538.500
|
| Concept/Terms |
HIV Fusion Inhibitors- HIV Fusion Inhibitors
- HIV Cell Fusion Inhibitors
- HIV Fusion Protein Inhibitors
- Fusion Inhibitors, HIV
|
Below are MeSH descriptors whose meaning is more general than "HIV Fusion Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "HIV Fusion Inhibitors".
This graph shows the total number of publications written about "HIV Fusion Inhibitors" by people in this website by year, and whether "HIV Fusion Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HIV Fusion Inhibitors" by people in Profiles.
-
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):473-83.
-
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity. Nat Biotechnol. 2013 Nov; 31(11):1047-52.
-
Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor. J Virol. 2013 Feb; 87(3):1899-905.
-
Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs. Semin Pediatr Infect Dis. 2005 Apr; 16(2):116-24.